Skip to main content
. Author manuscript; available in PMC: 2013 Aug 2.
Published in final edited form as: Am J Obstet Gynecol. 2005 Sep;193(3 0 2):1065–1070. doi: 10.1016/j.ajog.2005.05.087

Table 2. Indication for Induction.

High-Dose Vaginal Misoprostol (n=20) Concentrated Oxytocin + Low-dose Vaginal PGE1 (n=18) p value



Fetal Anomaly/Aneuploidy 65.0% (13/20) 66.7% (12/18)
Preterm Premature Rupture of Membranes 20.0% (2/20) 5.5% (1/18)
Fetal Demise 10.0% (4/20) 16.7% (3/18)
Maternal Indication 5.0% (1/20) 11.1% (2/18) 0.831